Xenon Seven
Director, Commercial Learning & Field Enablement
United States · Director
Sponsorship not specifiedDetected 25 days ago
RESTStakeholder ManagementBrand StrategyHRCadenceClinical TrialsLeadershipCommunication
About the role
- Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications.
- We also have multiple Phase 3 azetukalner clinical trials underway in major depressive disorder (MDD) and bipolar depression (BPD), based on topline data from our Phase 2 X-NOVA clinical trial.
- We continue to advance an early-stage pipeline of novel therapeutic candidates, including Phase 1 studies for XEN1701 (targeting Nav1.7) and XEN1120 (targeting Kv7), which are important pain targets.
Responsibilities
- Design and implement comprehensive training programs across:
- Own training readiness for launch, including curriculum design, certification, and delivery
- Partner with Sales and Marketing to align training to brand strategy, messaging, and milestones
- Design and implement leadership development programs for Regional Sales Managers and emerging leaders
- Equip front-line leaders with frameworks, tools, and approaches to effectively coach and develop their teams
- Partner with HR to align with enterprise leadership development initiatives
- Training Design & Delivery
- Develop and propose short- and long-term objectives for the function in accordance with overall Company strategies and plans
- Plan and manage budget proposals and approved budgets in accordance with the Company's strategic and operating plans and Finance policies
Requirements
- Proven experience designing and delivering commercial training programs aligned to launch and performance outcomes
- Ability to translate business strategy into measurable capability programs
- Bachelor's degree required; advanced degree preferred
- 10+ years of biopharma commercial experience across sales, training, learning & development, or commercial operations
- Deep understanding of adult learning principles and commercial field models
- Experience developing leadership programs for front-line leaders
- Strong facilitation, communication, and stakeholder management skills
- Experience with learning systems and platforms preferred
- Willingness to travel up to 40%-50%
Nice to have
- Bachelor's degree required
- advanced degree preferred
Compensation
- Our Total Rewards program includes base salary, target bonus, and stock options, as well as a full range of benefits including medical, dental, vision, short-& long-term disability, accidental death & dismemberment, and life insurance progr
Benefits
- Commercial Learning Strategy & Execution
- Define and execute a holistic commercial learning strategy aligned to business priorities and go-to-market objectives
- Product, disease state, and market access education
- Build structured learning journeys spanning onboarding, advanced development, and ongoing capability enhancement
- Translate strategic priorities into role-specific, applied learning experiences
- Develop high-quality, engaging learning experiences including workshops, virtual sessions, simulations, and e-learning
- Commercial Meetings & Learning Integration
- Lead the learning strategy and training components of national and regional meetings
Company info
- Xenon Pharmaceuticals (NASDAQ:XENE https://www.nasdaq.com/market-activity/stocks/xene) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.
- What We Do:
- We are advancing an exciting product pipeline https://xenon-pharma.com/pipeline to address indications with high unmet medical need, including epilepsy, depression and pain. Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we anticipate submitting a New Drug Application to the Food and Drug Administration in the third quarter of 2026. Our Phase 3 epilepsy program also includes a second FOS study, X-TOLE3, which would support regulatory submissions outside the U.S., and the X-ACKT study in primary generalized tonic-clonic seizures, which would support regulatory submissions for an additional epilepsy indication. We also have multiple Phase 3 azetukalner clinical trials underway in major depressive disorder (MDD) and bipolar depression (BPD), based on topline data from our Phase 2 X-NOVA clinical trial. In addition, we are proud of our strong heritage in human genetics, deep understanding of ion channel biology, and expertise in novel chemistries to enable potent, selective ion channel targeting. We continue to advance an early-stage pipeline of novel therapeutic candidates, including Phase 1 studies for XEN1701 (targeting Nav1.7) and XEN1120 (targeting Kv7), which are important pain targets. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
- The Director, Commercial Learning & Field Enablement is responsible for defining and delivering a comprehensive commercial learning strategy that builds field capability, supports launch readiness, and enables sustained commercial performance across Xenon's U.S. organization.
- Xenon Pharmaceuticals (NASDAQ:XENE https://www.nasdaq.com/market-activity/stocks/xene) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need.
- We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.
- We are advancing an exciting product pipeline https://xenon-pharma.com/pipeline to address indications with high unmet medical need, including epilepsy, depression and pain.
- In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we anticipate submitting a New Drug Application to the Food and Drug Administration in the third quarter of 2026.
- Our Phase 3 epilepsy program also includes a second FOS study, X-TOLE3, which would support regulatory submissions outside the U.S., and the X-ACKT study in primary generalized tonic-clonic seizures, which would support regulatory submissions for an additional epilepsy indication.
- In addition, we are proud of our strong heritage in human genetics, deep understanding of ion channel biology, and expertise in novel chemistries to enable potent, selective ion channel targeting.
- Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
- This role owns the design, development, and delivery of all commercial training programs, ensuring field teams are equipped with the knowledge, skills, and behaviors required to execute effectively.
- The Director will build and scale a best-in-class learning ecosystem, integrating functional training, leadership development, and enterprise training to support both immediate launch needs and long-term capability building.
- Acting as a strategic partner across Sales, Marketing, Market Access, Medical, Commercial Operations, and Human Resources, this role translates commercial strategy into structured, role-specific learning programs that enable field readiness and performance.
- This position reports to the Senior Director, Field Strategy & Enablement and is a key member of the extended commercial leadership team.
- This position will be remote.
Apply directly at Xenon Seven →Create a free account for alerts like thisView Xenon Seven immigration profile
This listing is sourced directly from Xenon Seven's careers page and normalized into a canonical job model.